Back
Palisade Bio, Inc. Vs. BlueLinx Holdings, Inc. Industry Stock Comparison
Sell
50
PALI
Palisade Bio, Inc.
Last Price:
$2.10
Seasonality Move:
-1.59%
Buy
51
BXC
BlueLinx Holdings, Inc.
Last Price:
$61.33
Seasonality Move:
23.8%
Sell
50
Palisade Bio, Inc. (PALI)
is a Sell
Is Palisade Bio, Inc. a Buy, Sell or Hold?
-
The current Palisade Bio, Inc. [PALI] share price is $2.08. The Score for PALI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
PALI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
BlueLinx Holdings, Inc. (BXC)
is a Buy
Is BlueLinx Holdings, Inc. a Buy, Sell or Hold?
-
The current BlueLinx Holdings, Inc. [BXC] share price is $60.87. The Score for BXC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
BXC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PALI Stock Price Chart
What is Palisade Bio, Inc.'s stock price today?
-
The Palisade Bio, Inc. share price today is $2.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PALI is experiencing slight buying pressure.
BXC Stock Price Chart
What is BlueLinx Holdings, Inc.'s stock price today?
-
The BlueLinx Holdings, Inc. share price today is $60.87Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BXC is experiencing selling pressure, which indicates risk of future bearish movement.
PALI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 55.98 | Buy |
| Chaikin Money Flow: | 2732231 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.77 - 2.17) | Buy |
| Bollinger Bands (100): | (0.8 - 2) | Buy |
BXC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 45.8 | Sell |
| Chaikin Money Flow: | -57962 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.91 - 64.47) | Buy |
| Bollinger Bands (100): | (61.87 - 78.87) | Sell |
PALI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.87 | Buy |
| 20-day SMA: | 1.93 | Buy |
| 50-day SMA: | 1.9 | Buy |
| 200-day SMA: | 1.08 | Buy |
| 8-day EMA: | 1.18 | Buy |
| 20-day EMA: | 0.6 | Buy |
| 50-day EMA: | 0.27 | Buy |
| 200-day EMA: | 0.07 | Buy |
BXC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.89 | Sell |
| 20-day SMA: | 62.24 | Sell |
| 50-day SMA: | 63.61 | Sell |
| 200-day SMA: | 72.07 | Sell |
| 8-day EMA: | 62.87 | Sell |
| 20-day EMA: | 62.39 | Sell |
| 50-day EMA: | 64.25 | Sell |
| 200-day EMA: | 74.6 | Sell |
Palisade Bio, Inc. Earnings Growth & PALI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.02 per share, and an increase next year of $0.45 per share.
BlueLinx Holdings, Inc. Earnings Growth & BXC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, a decrease this year of $5.29 per share, and an increase next year of $0.86 per share.
Palisade Bio, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BlueLinx Holdings, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||